Company Filing History:
Years Active: 2017-2024
Title: Innovations by Rose Viscardi: Pioneering Advances in Medical Diagnostics
Introduction
Rose Viscardi, located in Timonium, MD, is a remarkable inventor with a focus on enhancing medical diagnostics for vulnerable populations, particularly preterm infants. With a portfolio of two patents, her innovative approaches are transforming the landscape of neonatal care.
Latest Patents
One of Viscardi's notable patents is titled "Composition and methods for predicting necrotizing enterocolitis in preterm infants." This invention reveals a correlative finding between increased Clostridiales and/or Bifidobacteriales bacterial abundance in the gut and the maturation of the intestinal barrier in preterm neonates at risk for necrotizing enterocolitis (NEC). Her work allows for the identification of preterm infants who are at risk of developing this serious condition, along with methods for treating these infants and characterizing their intestinal permeability.
Another significant patent by Viscardi is the "Non-invasive analyte sensing system and method." This system is particularly beneficial for the transcutaneous monitoring of arterial blood gases in mammals. It operates by allowing the analyte to diffuse into a chamber where optical chemical sensors and associated optoelectronics can remotely sense the analyte, facilitating non-invasive monitoring.
Career Highlights
Rose Viscardi is affiliated with the University of Maryland, Baltimore, where she applies her expertise to advance medical research. Her dual focus on both clinical and technological aspects helps bridge gaps in neonatal health care.
Collaborations
Throughout her career, Viscardi has collaborated with esteemed colleagues such as Govind Rao and Yordan Kostov. Their collective efforts signify the importance of interdisciplinary teamwork in driving forward medical innovations that can save lives.
Conclusion
Rose Viscardi's contributions through her inventions reflect a deep commitment to improving neonatal care. Her innovative patents are set to provide new insights and methods for monitoring and treating preterm infants, showcasing the significant impact that dedicated inventors can have on healthcare advancements.